
Event Horizon
27 Old Gloucester Street, London, WC1N 3AX, United Kingdom
Overview
At Event Horizon, they accelerate great ideas from initial conception through to market. They focus on understanding and testing value-proposition and growth assumptions, product/market, and overarching business and product strategy. They use this understanding, coupled with their love for cutting-edge technology and big-picture thinking, to build exceptional businesses.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Incubators
- Product Design
Investment portfolio
- DreamBig Semiconductor
Participated · Series B · Jul 2024
DreamBig Semiconductor develops a chiplet platform that enables modular semiconductor solutions centered on its Chiplet Hub™ and Platform Chiplets. The company offers high-performance accelerator platforms and networking chiplets targeting LLMs, generative AI, data centers, edge computing, and automotive applications. Key capabilities include universal architecture support for CPU, AI, accelerator, I/O, networking, and memory chiplets within a unified platform and a Memory-First Architecture providing direct access to 3D stacked HBM, DDR, CXL, and SSD memory tiers. Additional technical features highlighted are fully associative hardware acceleration for cache/memory management (FLC Technology Group), DMA hardware for efficient transfers, a virtual PCIe/CXL switch, Ethernet/UEC RDMA hardware, and multi‑gigabit, low‑power CAM for 800Gbps match/action processing. The company intends to use the recently raised funds to accelerate development and commercialization of products built on its Chiplet Hub and Platform Chiplets. Led by CEO Sohail Syed, DreamBig positions itself to scale processor, accelerator, and networking chiplets across heterogeneous memory and compute domains.
- SynPhNe
Led · Series A · Mar 2024
SynPhNe develops medical wearable devices aimed at aiding rehabilitation for stroke and brain‑injury patients. Its core products are wearable devices designed to support patient recovery after neurological injury. The company was reported to have completed a financing round in March 2024. The reported financing totaled $5 million in a Series A. Event Horizon is named as the investor in the report.
Team
Ian Wood
Co-founder
LinkedIn